Opendata, web and dolomites
H2020 projects about "rheumatoid"
The page lists 53 projects related to the topic "rheumatoid".
| # | |||
|---|---|---|---|
| 1 | GLORIA | Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis | 2015 |
| 2 | ELECTOR | eHealth in Rheumatology | 2015 |
| 3 | HYMADE | Hybrid Drug Delivery Systems upon Mesoporous Materials, Self Assembled Therapeutics and Virosomes | 2015 |
| 4 | FIND | Feasibility Assessment of a Foot INflammation Detection Device | 2014 |
| 5 | iRhom2 in AD | iRhom2 in neuroinflammation and pathogenesis of Alzheimer’s Disease | 2015 |
| 6 | ADDITION | Arthritis Differential DIagnostic validaTION | 2015 |
| 7 | ImmRisk | Defining how environmental factors influence downstream effects of immune-mediated disease risk-SNPs | 2015 |
| 8 | RABIOPRED | RABIOPRED - Clinical validation of BIOmarker assay to PREDict treatment response in Rheumatoid Arthritis (RA) patients | 2015 |
| 9 | AutArt | Clinical validation of the AutArt rheumatoid arthritis diagnostic device | 2015 |
| 10 | TIPPDECRA | Tolerogenic immunotherapy with peptide-pulsed dendritic cells in rheumatoid arthritis | 2016 |
| 11 | ProteinConjugates | A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates | 2015 |
| 12 | IL7sigNETure | IL-7/IL-7R signaling networks in health and malignancy | 2015 |
| 13 | M-Imm | Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells | 2015 |
| 14 | PREG-LAB | Distinctive characterization of regulatory plasma cells and pro-inflammatory B cells in immunity: their origins, molecular properties, and cellular fates. | 2016 |
| 15 | REPROGRAM | Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases | 2016 |
| 16 | RELENT | RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities | 2015 |
| 17 | IMPEDE | Immunomodulatory effects of sustained pantethine release in inflammatory diseases | 2016 |
| 18 | FOLSMART | Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis | 2016 |
| 19 | DeBoRA | Dopamine and Bone Metabolism in Rheumatoid Arthritis | 2016 |
| 20 | GlySign | Exploitation of Glycosylation Signatures for Precision Medicine | 2016 |
| 21 | ADIBAS | Auotmatic Digital Biometry Analysis System for musculoskeletal disorders rehabilitation | 2017 |
| 22 | NOTID | Novel treatment of inflammatory diseases | 2016 |
| 23 | ExtremoChem | Chemically synthesised novel compounds for the stabilisation of biologics | 2016 |
| 24 | HarmonicSS | HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making | 2017 |
| 25 | SYSCID | A Systems medicine approach to chronic inflammatory disease | 2017 |
| 26 | INVESTIGERFE | Investigating the regulation of iron homeostasis by erythroferrone and therapeutic applications | 2017 |
| 27 | MaRiA | Microbiota and Resolvins in Arthritis | 2017 |
| 28 | RACE | Rheumatoid Arthritis Caught Early: investigating biological mechanisms preceding chronification of joint inflammation to identify patients prior to presentation of classic chronic arthritis | 2017 |
| 29 | LUMABS | Therapeutic antibody drug monitoring using bioluminescent sensors proteins and a smartphone | 2017 |
| 30 | AUTOCOMPLEMENT | The role of complement in the induction of autoimmunity against post-translationally modified proteins | 2017 |
| 31 | METAMAPPER | Super-resolution genomic mapping for the microbiome | 2017 |
| 32 | COSMIC | COmbatting disorders of adaptive immunity with Systems MedICine | 2018 |
| 33 | SmallDrugRheuma | Discovery of Immune Therapeutic Targets and Immunomodulators for the Development of Novel Therapies in Rheumatoid Arthritis. | 2018 |
| 34 | PREVENT RA | Towards prevention of autoimmune diseases: the case of rheumatoid arthritis | 2018 |
| 35 | QuanTII | Quantitative T cell Immunology and Immunotherapy | 2018 |
| 36 | IMMUNEDIVERSITY | Defining of human adaptive immune gene diversity and its impact on disease | 2018 |
| 37 | ReHub | Rehabilitation Hub: The World’s first Digital Recovery Therapy solution | 2018 |
| 38 | RheumArth | New drug for the treatment of rheumatoid arthritis | 2018 |
| 39 | PermeAbility | PermeAbility - A non-invasive, side-effect-free diagnostic kit for intestinal disorders | 2018 |
| 40 | BonePainII | A European Training Network to Combat Bone Pain | 2019 |
| 41 | EPI-X4Health | Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases | 2018 |
| 42 | Notid | Novel Target for Treatment of Chronic Inflammatory Diseases | 2018 |
| 43 | inCITe | Seeing Citrulline: A Molecular Toolbox for Peptidyl Arginine Deiminases | 2019 |
| 44 | NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | 2019 |
| 45 | ArthritisHeal | Establishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis | 2019 |
| 46 | CVD in RA | Mechanistic links between rheumatoid arthritis and cardiovascular complications: investigation on inflammation induced alterations in induced pluripotent stem cell-derived cardiomyocytes | 2020 |
| 47 | ARCAID | Amsterdam Rheumatology Center for AutoImmune Diseases | 2020 |
| 48 | AstaFerm | A natural and high quality ingredient for dietary supplement derived from yeast fermentation to reduce oxidative stress and promote health and wellbeing | 2019 |
| 49 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 50 | PAPRAT | PAPRAT (Predictive Algorithm for Pre-Rheumatoid Arthritis Treatment). The new and most efficient multiple biomarkers-based system for an early selection of RA treatment intensity | 2019 |
| 51 | InflaCare | An exosome-based therapeutic approach against chronic inflammation | 2020 |
| 52 | DocTIS | DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES | 2020 |
| 53 | ExpoBiome | Deciphering the impact of exposures from the gut microbiome-derived molecular complex in human health and disease | 2020 |